Inventor
Ching-Leou Teng
Inventor
San Diego, CA, US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07HSugars17%
Y02ATechnologies for adaptation to climate change17%
C07KPeptides6%
C12NMicroorganisms or enzymes6%
PatentTitleYear
8,691,785'Compositions and methods for non-parenteral delivery of oligonucleotides'20148,377,897'Compositions and methods for non-parenteral delivery of oligonucleotides'20138,106,160'N-terminal modified interferon-alpha'20126,887,906'Compositions and methods for the delivery of oligonucleotides via the alimentary canal'20056,747,014'Compositions and methods for non-parenteral delivery of oligonucleotides'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2014Patents assigned to ISIS PHARMACEUTICALS INC (3)· patent assignee history
2004–2014Based in San Diego, CA, US· patent location history
2012–2013Patents assigned to TENG CHING-LEOU (2)· patent assignee history
2013Patents assigned to COOK PHILLIP DAN (1)· patent assignee history
2013Patents assigned to ECKER DAVID J (1)· patent assignee history
2013Patents assigned to HARDEE GREGORY E (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ISIS PHARMACEUTICALS INC | 3 | 2004–2014 |
| TENG CHING-LEOUself | 2 | 2012–2013 |
| COOK PHILLIP DAN | 1 | 2013 |
| ECKER DAVID J | 1 | 2013 |
| HARDEE GREGORY E | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 5 | 2004–2014 |